{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:31:21Z","timestamp":1782405081646,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00066-021-01798-x","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T16:23:17Z","timestamp":1623342197000},"page":"1104-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location"],"prefix":"10.1007","volume":"197","author":[{"given":"Siujoon","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seringe","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald B.","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo S.","family":"Carlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brindha S.","family":"Shivalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"issue":"4","key":"1798_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/pcmr.12682","volume":"31","author":"M Tio","year":"2018","unstructured":"Tio\u00a0M et\u00a0al (2018) Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy. Pigment Cell Melanoma Res 31(4):509\u2013515","journal-title":"Pigment Cell Melanoma Res"},{"issue":"16","key":"1798_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin\u00a0J et al (2019) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N\u00a0Engl J Med 381(16):1535\u20131546","journal-title":"N Engl J Med"},{"issue":"8","key":"1798_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","volume":"379","author":"HA Tawbi","year":"2018","unstructured":"Tawbi\u00a0HA et\u00a0al (2018) Combined nivolumab and Ipilimumab in melanoma metastatic to the brain. N\u00a0Engl J Med 379(8):722\u2013730","journal-title":"N Engl J Med"},{"issue":"5","key":"1798_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","volume":"19","author":"GV Long","year":"2018","unstructured":"Long\u00a0GV et\u00a0al (2018) Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a\u00a0multicentre randomised phase 2\u00a0study. Lancet Oncol 19(5):672\u2013681","journal-title":"Lancet Oncol"},{"issue":"3","key":"1798_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11060-017-2470-4","volume":"133","author":"P Fang","year":"2017","unstructured":"Fang\u00a0P et al (2017) Radiation necrosis with stereotactic radiosurgery combined with CTLA\u20114 blockade and PD\u20111 inhibition for treatment of intracranial disease in metastatic melanoma. J\u00a0Neurooncol 133(3):595\u2013602","journal-title":"J Neurooncol"},{"key":"1798_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fonc.2012.00073","volume":"2","author":"D Greene-Schloesser","year":"2012","unstructured":"Greene-Schloesser\u00a0D et al (2012) Radiation-induced brain injury: a review. Front Oncol 2:73","journal-title":"Front Oncol"},{"issue":"2","key":"1798_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed\u00a0PK et\u00a0al (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J\u00a0Neurosurg 123(2):373\u2013386","journal-title":"J Neurosurg"},{"issue":"6","key":"1798_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/CAD.0000000000000497","volume":"28","author":"O Kaidar-Person","year":"2017","unstructured":"Kaidar-Person\u00a0O et al (2017) The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy. Anticancer Drugs 28(6):669\u2013675","journal-title":"Anticancer Drugs"},{"issue":"1","key":"1798_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40425-019-0588-y","volume":"7","author":"G Minniti","year":"2019","unstructured":"Minniti\u00a0G et\u00a0al (2019) Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity. J\u00a0Immunother Cancer 7(1):102","journal-title":"J Immunother Cancer"},{"issue":"4","key":"1798_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/pcmr.12775","volume":"32","author":"I Pires da Silva","year":"2019","unstructured":"Pires da Silva\u00a0I et al (2019) Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD\u20111 antibodies. Pigment Cell Melanoma Res 32(4):553\u2013563","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"1798_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3171\/2017.1.JNS162797","volume":"129","author":"R Kotecha","year":"2018","unstructured":"Kotecha\u00a0R et al (2018) Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and\/or immune-based therapies on treatment outcome. J\u00a0Neurosurg 129(1):50\u201359","journal-title":"J Neurosurg"},{"issue":"9","key":"1798_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/0360-3016(80)90175-3","volume":"6","author":"GE Sheline","year":"1980","unstructured":"Sheline\u00a0GE, Wara\u00a0WM, Smith\u00a0V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6(9):1215\u20131228","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1798_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2214\/ajr.149.1.165","volume":"149","author":"JS Tsuruda","year":"1987","unstructured":"Tsuruda\u00a0JS et\u00a0al (1987) Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 149(1):165\u2013171","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1798_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3892\/etm.2014.1802","volume":"8","author":"S Kudo","year":"2014","unstructured":"Kudo\u00a0S et\u00a0al (2014) Comparison of the radiosensitivities of neurons and glial cells derived from the same rat brain. Exp Ther Med 8(3):754\u2013758","journal-title":"Exp Ther Med"},{"issue":"4","key":"1798_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00795-015-0123-2","volume":"48","author":"M Furuse","year":"2015","unstructured":"Furuse\u00a0M et\u00a0al (2015) Delayed brain radiation necrosis: pathological review and new molecular targets for treatment. Med Mol Morphol 48(4):183\u2013190","journal-title":"Med Mol Morphol"},{"issue":"7","key":"1798_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2217\/fon.13.271","volume":"10","author":"AJ Walker","year":"2014","unstructured":"Walker\u00a0AJ et\u00a0al (2014) Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol 10(7):1277\u20131297","journal-title":"Future Oncol"},{"issue":"1","key":"1798_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","volume":"125","author":"ZA Kohutek","year":"2015","unstructured":"Kohutek\u00a0ZA et al (2015) Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. J\u00a0Neurooncol 125(1):149\u2013156","journal-title":"J Neurooncol"},{"key":"1798_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.nicl.2018.08.024","volume":"20","author":"P Lohmann","year":"2018","unstructured":"Lohmann\u00a0P et\u00a0al (2018) Combined FET PET\/MRI radiomics differentiates radiation injury from recurrent brain metastasis. Neuroimage Clin 20:537\u2013542","journal-title":"Neuroimage Clin"},{"issue":"1","key":"1798_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-009-0106-z","volume":"99","author":"K Mitsuya","year":"2010","unstructured":"Mitsuya\u00a0K et\u00a0al (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J\u00a0Neurooncol 99(1):81\u201388","journal-title":"J Neurooncol"},{"issue":"1","key":"1798_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11060-012-0834-3","volume":"108","author":"K Ohtakara","year":"2012","unstructured":"Ohtakara\u00a0K et al (2012) Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases. J\u00a0Neurooncol 108(1):201\u2013209","journal-title":"J Neurooncol"},{"issue":"2","key":"1798_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijrobp.2005.07.980","volume":"64","author":"T Korytko","year":"2006","unstructured":"Korytko\u00a0T et al (2006) 12\u202fGy gamma knife radiosurgical volume is a\u00a0predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64(2):419\u2013424","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1798_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti\u00a0G et\u00a0al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48","journal-title":"Radiat Oncol"},{"issue":"4","key":"1798_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/CMR.0000000000000268","volume":"26","author":"KR Patel","year":"2016","unstructured":"Patel\u00a0KR et\u00a0al (2016) BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma Res 26(4):387\u2013394","journal-title":"Melanoma Res"},{"issue":"5","key":"1798_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ijrobp.2016.08.039","volume":"96","author":"JA Miller","year":"2016","unstructured":"Miller\u00a0JA et\u00a0al (2016) Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 96(5):1060\u20131069","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"1798_CR25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","volume":"4","author":"AM Martin","year":"2018","unstructured":"Martin\u00a0AM et\u00a0al (2018) Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation. JAMA Oncol 4(8):1123\u20131124","journal-title":"JAMA Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01798-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-021-01798-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01798-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:03:16Z","timestamp":1637319796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-021-01798-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1798"],"URL":"https:\/\/doi.org\/10.1007\/s00066-021-01798-x","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Choi, A.\u00a0Hong, T.\u00a0Wang, S.\u00a0Lo, B.\u00a0Chen, I.\u00a0Silva, R.\u00a0Kapoor, E.\u00a0Hsiao, G.\u00a0B.\u00a0Fogarty, M.\u00a0S.\u00a0Carlino, A.\u00a0M.\u00a0Menzies, G.\u00a0V.\u00a0Long and B.\u00a0S.\u00a0Shivalingam declare that they have no competing interests. We confirm that this manuscript is original and is not being considered for publication elsewhere. All figures and tables in this manuscript have been created by the authors of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional (granted by the Melanoma Institute of Australia) and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}